Literature DB >> 11770995

Influence of environmental and genetic factors on allergen-specific immunoglobulin-E levels in sera from Lipizzan horses.

C Eder1, I Curik, G Brem, R Crameri, I Bodo, F Habe, S Lazary, J Sölkner, E Marti.   

Abstract

To investigate whether allergen-specific IgE production is influenced by environmental and genetic factors, IgE levels against 2 mould extracts (Alternaria alternata [Alt a] and Aspergillus fumigatus [Asp f]) and against recombinant (r) rAlt a 1, rAsp f 7 and rAsp f 8 were determined by ELISA in sera from 448 Lipizzan horses living in 6 studfarms. Statistical evaluation showed a significant effect of studfarm-specific environment on IgE levels against the different allergens, but genetic factors also influenced allergen-specific IgE production: an heritability of 0.33 was found for IgE levels against the 2 mould extracts and of 0.21 for rAsp f 8-specific IgE. Heritability estimates for rAlt a 1- and rAsp f 7-specific IgE were negligible. Investigations for a possible association between Major Histocompatibility Complex (MHC) class I antigens and specific IgE levels were carried out. The most consistent significant association was found between the equine leucocyte antigen (ELA) A8 and undetectable IgE titres against rAsp f 7 and rAsp f 8. Significant ELA associations were also demonstrated between ELA A1 and higher specific IgE levels, between ELA A14 and lower IgE levels against the mould extracts and in one studfarm between ELA Be27 and lower Aspergillus-specific IgE levels.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11770995     DOI: 10.2746/042516401776249264

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  8 in total

1.  Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcεRI.

Authors:  Sari Sabban; Hongtu Ye; Birgit Helm
Journal:  J Vis Exp       Date:  2014-11-01       Impact factor: 1.355

2.  Detection of reaginic antibodies against Faenia rectivirgula from the serum of horses affected with Recurrent Airway Obstruction by an in vitro bioassay.

Authors:  Gabriel Morán; Hugo Folch; Oscar Araya; Rafael Burgos; Miguel Barria
Journal:  Vet Res Commun       Date:  2010-09-03       Impact factor: 2.459

3.  Reaginic antibodies from horses with recurrent airway obstruction produce mast cell stimulation.

Authors:  G Moran; H Folch; C Henriquez; A Ortloff; M Barria
Journal:  Vet Res Commun       Date:  2012-08-12       Impact factor: 2.459

4.  Increased apoptosis of CD4 and CD8 T lymphocytes in the airways of horses with recurrent airway obstruction.

Authors:  Gabriel Moran; Virginia A Buechner-Maxwell; Hugo Folch; Claudio Henriquez; Juan S Galecio; Barbara Perez; Cristian Carrasco; Miguel Barria
Journal:  Vet Res Commun       Date:  2011-05-19       Impact factor: 2.459

5.  In vitro bioassay to detect reaginic antibodies from the serum of horses affected with recurrent airway obstruction.

Authors:  Gabriel Morán; Rafael Burgos; Oscar Araya; Hugo Folch
Journal:  Vet Res Commun       Date:  2009-12-10       Impact factor: 2.459

6.  Apoptotic effects of tamoxifen on leukocytes from horse peripheral blood and bronchoalveolar lavage fluid.

Authors:  J Sarmiento; B Perez; N Morales; C Henriquez; L Vidal; H Folch; J S Galecio; G Morán
Journal:  Vet Res Commun       Date:  2013-07-12       Impact factor: 2.459

7.  Copy number variations in Friesian horses and genetic risk factors for insect bite hypersensitivity.

Authors:  Anouk Schurink; Vinicius H da Silva; Brandon D Velie; Bert W Dibbits; Richard P M A Crooijmans; Liesbeth Franҫois; Steven Janssens; Anneleen Stinckens; Sarah Blott; Nadine Buys; Gabriella Lindgren; Bart J Ducro
Journal:  BMC Genet       Date:  2018-07-30       Impact factor: 2.797

8.  Development of a comprehensive protein microarray for immunoglobulin E profiling in horses with severe asthma.

Authors:  Samuel White; Meriel Moore-Colyer; Eliane Marti; Laurent Coüetil; Duncan Hannant; Eric A Richard; Marcos Alcocer
Journal:  J Vet Intern Med       Date:  2019-08-20       Impact factor: 3.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.